These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33773066)

  • 1. Interaction of leachable model compounds and their impact on Chinese hamster ovary cell cultivation.
    Budde D; Albano GL; Noll T; Jurkiewicz E
    Biotechnol Prog; 2021 Jul; 37(4):e3150. PubMed ID: 33773066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative characterization of leachables sinks in biopharmaceutical downstream processing.
    Paudel K; Hauk A; Maier TV; Menzel R
    Eur J Pharm Sci; 2020 Feb; 143():105069. PubMed ID: 31634555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvements in single-use bioreactor film material composition leads to robust and reliable Chinese hamster ovary cell performance.
    Kelly PS; Dorival-García N; Paré S; Carillo S; Ta C; Alarcon Miguez A; Coleman O; Harper E; Shannon M; Henry M; Connolly L; Clynes M; Meleady P; Bones J; Barron N
    Biotechnol Prog; 2019 Jul; 35(4):e2824. PubMed ID: 31017345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of solvent systems for optimized extractables studies of single use bioprocessing solutions.
    Dorival-García N; Bones J
    J Chromatogr A; 2017 Sep; 1513():69-77. PubMed ID: 28739275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Filtration membranes - Scavengers for leachables?
    Hauk A; Jurkiewicz E; Pahl I; Loewe T; Menzel R
    Eur J Pharm Sci; 2018 Jul; 120():191-198. PubMed ID: 29719239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuating apoptosis in Chinese hamster ovary cells for improved biopharmaceutical production.
    Henry MN; MacDonald MA; Orellana CA; Gray PP; Gillard M; Baker K; Nielsen LK; Marcellin E; Mahler S; Martínez VS
    Biotechnol Bioeng; 2020 Apr; 117(4):1187-1203. PubMed ID: 31930480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased recombinant protein production owing to expanded opportunities for vector integration in high chromosome number Chinese hamster ovary cells.
    Yamano N; Takahashi M; Ali Haghparast SM; Onitsuka M; Kumamoto T; Frank J; Omasa T
    J Biosci Bioeng; 2016 Aug; 122(2):226-31. PubMed ID: 26850366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-concentration staurosporine improves recombinant antibody productivity in Chinese hamster ovary cells without inducing cell death.
    Kido M; Idogaki H; Nishikawa K; Omasa T
    J Biosci Bioeng; 2020 Nov; 130(5):525-532. PubMed ID: 32800439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk analysis of leachables in cell and gene therapy using a CAR-T model process.
    Budde D; Jurkiewicz E
    Int J Pharm; 2021 Sep; 607():121015. PubMed ID: 34411651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of high-producing cell lines by overexpression of cell division cycle 25 homolog A in Chinese hamster ovary cells.
    Lee KH; Tsutsui T; Honda K; Asano R; Kumagai I; Ohtake H; Omasa T
    J Biosci Bioeng; 2013 Dec; 116(6):754-60. PubMed ID: 23810665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of a PER.C6® cell line to bis(2,4-di-tert-butylphenyl)phosphate and evaluation of a new, biocompatible single-use film.
    Jachuck JR; Krishnathu SM; Landau JE; Ko HF; Bhatia R
    Biotechnol Prog; 2020 Nov; 36(6):e3060. PubMed ID: 32748552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino acid and glucose metabolism in fed-batch CHO cell culture affects antibody production and glycosylation.
    Fan Y; Jimenez Del Val I; Müller C; Wagtberg Sen J; Rasmussen SK; Kontoravdi C; Weilguny D; Andersen MR
    Biotechnol Bioeng; 2015 Mar; 112(3):521-35. PubMed ID: 25220616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell engineering and cultivation of chinese hamster ovary (CHO) cells.
    Omasa T; Onitsuka M; Kim WD
    Curr Pharm Biotechnol; 2010 Apr; 11(3):233-40. PubMed ID: 20210750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative analysis of recombinant Fab and full-length antibody production in Chinese hamster ovary cells.
    Hussain H; Patel T; Ozanne AMS; Vito D; Ellis M; Hinchliffe M; Humphreys DP; Stephens PE; Sweeney B; White J; Dickson AJ; Smales CM
    Biotechnol Bioeng; 2021 Dec; 118(12):4815-4828. PubMed ID: 34585737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biosorption of process-equipment-related leachables (PERLs) in biomanufacturing: A quantitative approach to study partitioning of PERLs in a cell culture system.
    Bossong M; Budde D; Hauk A; Pahl I; Menzel R; Langguth P
    Int J Pharm; 2023 Mar; 635():122742. PubMed ID: 36804518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lengthening of high-yield production levels of monoclonal antibody-producing Chinese hamster ovary cells by downregulation of breast cancer 1.
    Matsuyama R; Yamano N; Kawamura N; Omasa T
    J Biosci Bioeng; 2017 Mar; 123(3):382-389. PubMed ID: 27742176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of hydrolysates on monoclonal antibody productivity, purification and quality in Chinese hamster ovary cells.
    Ho SC; Nian R; Woen S; Chng J; Zhang P; Yang Y
    J Biosci Bioeng; 2016 Oct; 122(4):499-506. PubMed ID: 27067279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Peptone Supplementation in Different Culture Media on Growth, Metabolic Pathway and Productivity of CHO DG44 Cells; a New Insight into Amino Acid Profiles.
    Davami F; Eghbalpour F; Nematollahi L; Barkhordari F; Mahboudi F
    Iran Biomed J; 2015; 19(4):194-205. PubMed ID: 26232332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scalable transient gene expression in Chinese hamster ovary cells in instrumented and non-instrumented cultivation systems.
    Muller N; Derouazi M; Van Tilborgh F; Wulhfard S; Hacker DL; Jordan M; Wurm FM
    Biotechnol Lett; 2007 May; 29(5):703-11. PubMed ID: 17310326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impacts on product quality attributes of monoclonal antibodies produced in CHO cell bioreactor cultures during intentional mycoplasma contamination events.
    Fratz-Berilla EJ; Angart P; Graham RJ; Powers DN; Mohammad A; Kohnhorst C; Faison T; Velugula-Yellela SR; Trunfio N; Agarabi C
    Biotechnol Bioeng; 2020 Sep; 117(9):2802-2815. PubMed ID: 32436993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.